How Can We Help You?
Locations | Global Affiliations  
Open

Tag Archives: Healthcare

 HomeBizzell US  Blog  Healthcare
group of people in a circle looking down at the camera
Categories News Tags CEO News, Health, Healthcare, National Cancer Institute (NCI), Tobacco Research

Bizzell Supports Development of Comprehensive Report Addressing Smoking Cessation Treatment within Cancer Care Settings

Bizzell Supports Development of Comprehensive Report Addressing Smoking Cessation Treatment within Cancer Care Settings

 

July 27, 2022 (New Carrollton, MD) — The Bizzell Group is proud to provide direct support to the National Cancer Institute, part of the National Institutes of Health, in the development of Tobacco Control Monograph 23—Treating Smoking in Cancer Patients: An Essential Component of Cancer Care. Released on June 29th, the monograph expands upon prior research from the 2014 and 2020 Surgeon General’s reports to inform clinicians and their patients with cancer about the science and practice of quitting smoking. The monograph also builds on recent findings from the National Cancer Institute’s (NCI) Moonshot℠ Cancer Center Cessation Initiative (C3I) program. “The monograph provides evidence that clinicians, public health practitioners, researchers, and patients with cancer can use to help influence real-world change in the treatment of patients with cancer who smoke. I am grateful for the opportunity to collaborate with NCI and subject matter experts to produce a rigorous volume on such an important topic,” said Jenny Twesten, Managing Director of Health Communications & Research at Bizzell, who oversaw the editorial and publication support for the monograph.

Smoking cessation treatment is rarely addressed in cancer care settings, yet the research summarized in the monograph demonstrates that quitting smoking is among the most effective treatment options for improving the likelihood of survival, quality of life, and overall health of people with cancer who smoke. The monograph also provides clinicians with evidence-based strategies and treatment options they can implement to better address smoking with cancer patients.
“Monograph 23 leverages prior academic research to demonstrate that addressing smoking cessation within the cancer treatment protocol yields tremendous benefits. I am greatly appreciative of the rigorous development process led by the Federal staff, Scientific Editorial Committee, peer-review experts, and the Bizzell team” said Anton C. Bizzell, M.D., President and CEO of Bizzell.

To read the full monograph, please visit: https://cancercontrol.cancer.gov/brp/tcrb/monographs/monograph-23

About Bizzell

Established in 2010, Bizzell US is U.S. Small Business Administration (SBA) HUBZone certified strategy, consulting, and technology firm with a mission to improve lives and accelerate change. Bizzell US develops innovative solutions to some of the most critical issues of our time such as health care services equity, global health, workforce innovation and other urgent needs facing the world. Under the leadership and vision of founder, Anton C. Bizzell, MD, the company has grown into a thriving firm headquartered in New Carrollton, Maryland with staff and offices in various regions around the country including California, Colorado, Oklahoma, and Georgia, and globally in Africa, Asia, and Central America. Learn more about how we develop data-driven, research-informed, innovative solutions to complex-real-world challenges. Learn more at BizzellUS.com.

Categories News Tags Awards, Centers for Disease Control and Prevention (CDC), Centers for Medicare and Medicaid Services (CMS), Communications & Outreach, COVID-19, Food and Drug Administration (FDA), Health, Healthcare, Project Awards, Special Populations

Bizzell Wins Three MUSE Creative Awards for Public Health Projects

September 30, 2021 (New Carrollton, MD) – The Bizzell Group (Bizzell), one of the fastest growing companies in America according to Inc. Magazine and Washington Business Journal, has won three MUSE Creative Awards, including one Gold and two Silver awards. Bizzell was recognized for integrated marketing content, websites, and publications designed to support the U.S. Food and Drug Administration (FDA), Centers for Medicare & Medicaid Services (CMS), and the Centers for Disease Control and Prevention (CDC) to tackle critical public health issues including the COVID-19 pandemic.

This year, Bizzell received the Gold MUSE Creative Award for the BeSafeRx Relaunch, a national campaign sponsored by the FDA to educate consumers and healthcare providers about the potential dangers of buying prescription medicine online.

Bizzell received a Silver MUSE Creative Award for the CMS-CDC Fundamentals of COVID-19 Prevention for Nursing Home Management website—an on-demand nursing home training series designed to help address the infection prevention challenges impacting long-term care facilities due to the COVID-19 pandemic. Bizzell also received a Silver award for the CMS Toolkit on State Action to Mitigate COVID-19 Prevalence—a publication of curated content designed to facilitate and share best practices to manage the spread of COVID-19 in nursing homes.

Bizzell’s clients drive real world change and Bizzell staff accelerate it. According to Anton C. Bizzell, M.D., Founder and CEO of Bizzell, “during this COVID-19 pandemic, our clients need creativity and innovation. The Bizzell team delivered and disseminated solutions to help the public access critical information on prescriptions drugs and supported health care providers with enhanced quality improvement tools and resources during unprecedented times.”

The MUSE Awards is a series of international competitions hosted by the International Awards Associate (IAA), catering to professionals from various industries in hopes of promoting excellence in their respective fields. “There is a saying that ‘there is nothing new under the sun’,” said Kenjo Ong, CEO of IAA. “It couldn’t be any further from the truth – there is always something fresh and exciting from the competitors every year.”

IAA ensures impartiality and strict assessment criteria by setting up a jury made up of industry professionals who exhibit high standards of excellence. In turn, the jury would select a new wave of excellent individuals or organizations, who would likely set new benchmarks in their fields.

About The MUSE Creative Awards

The MUSE Creative Awards is part of the MUSE Awards Program, which was created by the IAA in 2015. IAA’s inception was based on a mission to honor, promote and encourage creativity by providing a new standard of excellence for evaluation media design production and distribution. IAA’s mission has largely shaped MCA’s goal.

At its core, MUSE Creative Awards international competition inspires creative professionals to strive for to greater heights. With their concepts, ideas or designs, these creatives light a fire in each other, thus becoming a muse.

Website: MUSE Creative Awards / MUSE Design Awards

Facebook: MUSE Awards

Twitter: MUSE Awards

Instagram: MUSE Awards 

About Bizzell

Established in 2010, The Bizzell Group (Bizzell) is a U.S. Small Business Administration (SBA) 8(a) certified strategy, consulting, and technology firm that designs innovative solutions to help build healthy, secure, and sustainable communities around the world. Bizzell’s expert staff and consultants support health, scientific, education, environmental, research, and information technology projects that advance national priorities. Learn more about how Bizzell develops data-driven, research-informed, innovative solutions at: www.BizzellUS.com.

Categories Insights Tags Health, Healthcare, National Cancer Institute (NCI), People First, Tobacco Research

Bizzell PD Co-Authors Manuscript in NTR

Jenny Twesten, MPH, Project Director of the National Cancer Institute, Tobacco Control Research Branch contract, co-authored a manuscript in the November issue of Nicotine & Tobacco Research (NTR) that was selected as an Editor’s Choice submission. The manuscript details the challenges of measuring cigarette smoking risk perceptions among adult smokers and non-smokers on questionnaires and opportunities for improved measurement based on current scientific evidence. The co-authors provide ten suggestions for researchers and survey developers to consider when assessing cigarette risk perceptions to improve how smoking risk perceptions may influence cigarette smoking behaviors.

Jenny is a public health communicator with more than seven years of experience providing clients with innovative solutions to disseminating research, synthesizing the state-of-the-science, and improving self-report assessments. She contributed to the production of two monographs, managed an extramural research portfolio, and led the early adoption of podcasts to disseminate research. As a Project Director at Bizzell, she provides research and communications guidance on a portfolio of tobacco and cancer-related projects, including co-authoring three tobacco control manuscripts and overseeing the implementation of two digital media campaigns. Her research interests are cancer prevention, early detection and survivorship, modifiable health behaviors such as tobacco use, and risk perception. She holds a Master of Public Health from George Washington University.

Nicotine & Tobacco Research (NTR) is one of the world’s few peer-reviewed journals devoted exclusively to the study of nicotine and tobacco. It aims to provide a forum for empirical findings, critical reviews, and conceptual papers on the many aspects of nicotine and tobacco, including research from the biobehavioral, neurobiological, molecular biologic, epidemiological, prevention, and treatment arenas.

Read Article: https://academic.oup.com/ntr/article/22/11/1937/5688704

Categories Insights Tags Centers for Medicare and Medicaid Services (CMS), Health, Healthcare, People First, Quality Improvement

Bizzell Senior Associate Featured in JAMDA Article

Mark Stewart, MPH, Senior Associate of Health Systems and Services, is an author on an in-press manuscript in The Journal of the Post-Acute and Long-Term Care Medicine (JAMDA). The article details a consensus-based definition for omissions of care in nursing homes that lead to increased risk for harm or adverse outcomes, decreased quality of life for residents, and increased healthcare expenditures. This definition is clear, meaningful, and actionable for nursing homes. Providers and researchers applying this definition can improve harm prevention and increase consistency in research methods.

Mark has more than 20 years of experience leading health innovation projects focused on ensuring the quality of care and improving outcomes. At Bizzell, he provides critical support to the organization managing, advising, and operationalizing projects advancing health systems and services improvements in areas such including person and family-centered care, shared decision making, patient-reported outcomes, healthcare disparities, and quality improvement. In addition, Mark serves as the Program Manager for the Centers for Medicare and Medicaid Services (CMS) Data Validation and Administrative (DVA) contract.

JAMDA is the leading peer-reviewed publication for practical information and research directly applicable to healthcare professionals providing post-acute and long-term care (PA/LTC), as well as policymakers, organizational leaders, educators, and advocates.

Read Article: https://www.jamda.com/article/S1525-8610(20)30706-4/fulltext

1 2 3
Copyright © 2023 Bizzell US All rights reserved.
Bizzell US